<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
  xmlns:dc="http://purl.org/dc/elements/1.1/"
  xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
  xmlns:admin="http://webns.net/mvcb/"
  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">

<channel>
<title>Brain Waves</title>
<link>/home/corante/public_html/brainwaves/</link>
<description>The field of neurotechnology, the focus of this blog, encompasses advances in brain science (neurons), information technology (bits) and bioengineering (genes).  Up for discussion and analysis: the political, economic, ethical, and social forces that will shape the future of what will be one of the most important and fascinating stories of the coming decades. </description>
<dc:language>en-us</dc:language>
<dc:creator>zack@neuroinsights.com</dc:creator>
<dc:date>2010-02-01T12:08:27-05:00</dc:date>
<admin:generatorAgent rdf:resource="http://www.movabletype.org/?v=3.34" />
<sy:updatePeriod>hourly</sy:updatePeriod>
<sy:updateFrequency>1</sy:updateFrequency>
<sy:updateBase>2000-01-01T12:00+00:00</sy:updateBase>

<item>
<title>Neuropharma FDA Approvals Down in 2009</title>
<link>http://brainwaves.corante.com/archives/2010/02/01/neuropharma_fda_approvals_down_in_2009.php</link>
<description>As we report today in this month&apos;s edition of Neurotech Insights, five of the 26 new drugs and biologics approved by the FDA were neuropharmaceuticals: Vanda/Novartis’ Fanapt for schizophrenia, Lundbeck&apos;s Sabril for infantile spasms and add-on for refractory partial seizures,...</description>
<guid isPermaLink="false">74255@/home/corante/public_html/brainwaves/</guid>
<dc:subject>Neuropharma</dc:subject>
<dc:date>2010-02-01T12:08:27-05:00</dc:date>
</item>
<item>
<title>CollabRx - Arming You to Race for Your Cure</title>
<link>http://brainwaves.corante.com/archives/2008/07/29/collabrx_arming_you_to_race_for_your_cure.php</link>
<description>Casey, Dan and I met with Marty Tenenbaum founder of CollabRx and Tony Ley its CEO last week to get up to speed on their strategy for providing tools to patient groups and virtual biotechs to accelerate the development of...</description>
<guid isPermaLink="false">73475@/home/corante/public_html/brainwaves/</guid>
<dc:subject>Neuropharma</dc:subject>
<dc:date>2008-07-29T12:39:36-05:00</dc:date>
</item>
<item>
<title>CDER Neurotech Drug Reviewers Up 15 to 91</title>
<link>http://brainwaves.corante.com/archives/2008/06/10/cder_neurotech_drug_reviewers_up_15_to_91.php</link>
<description>The Center for Drugs Evaluation and Research is about halfway through its planned hire of 663 employees this year, and a significant portion of the new employees are division-level medical reviewers in the Office of New Drugs. So far the...</description>
<guid isPermaLink="false">73358@/home/corante/public_html/brainwaves/</guid>
<dc:subject>Neuropharma</dc:subject>
<dc:date>2008-06-10T12:52:18-05:00</dc:date>
</item>
<item>
<title>Free Online Neuropsychopharmacology Textbook</title>
<link>http://brainwaves.corante.com/archives/2007/08/06/free_online_neuropsychopharmacology_textbook.php</link>
<description>The American College of Neuropsychopharmacology has just put a massive 134 chapter textbook online covering everything from neurotransmitters to functional imaging in psychiatry, all with free access. (Pointer, Neuroethics and Law, MindHacks). Correction 8/7: Turns out that this book is...</description>
<guid isPermaLink="false">72560@/home/corante/public_html/brainwaves/</guid>
<dc:subject>Neuropharma</dc:subject>
<dc:date>2007-08-06T11:08:52-05:00</dc:date>
</item>
<item>
<title>Pretty Pearlescent Pills - Colorful Drugs Approved by FDA</title>
<link>http://brainwaves.corante.com/archives/2006/07/27/pretty_pearlescent_pills_colorful_drugs_approved_by_fda.php</link>
<description>The FDA has OK&apos;d the use of &quot;pearlescent pigments&quot; in any drugs that are swallowed. The pigments, which are commonly used in cosmetics, are intended to give drugs a special, colorful look that some believe could help make these products...</description>
<guid isPermaLink="false">62613@/home/corante/public_html/brainwaves/</guid>
<dc:subject>Neuropharma</dc:subject>
<dc:date>2006-07-27T13:33:04-05:00</dc:date>
</item>
<item>
<title>Hear This!  New Hearing Loss Drug Enters Clinical Testing from Sound Pharmaceuticals</title>
<link>http://brainwaves.corante.com/archives/2006/06/12/hear_this_new_hearing_loss_drug_enters_clinical_testing_from_sound_pharmaceuticals.php</link>
<description>After receiving additional funding from DARPA this past winter Sound Pharmaceuticals has initiated clinical testing of SPI-1005 for the prevention and treatment of noise induced hearing loss. According to OSHA and the CDC, 30-40 million Americans are exposed to hazardous...</description>
<guid isPermaLink="false">59952@/home/corante/public_html/brainwaves/</guid>
<dc:subject>Neuropharma</dc:subject>
<dc:date>2006-06-12T12:19:23-05:00</dc:date>
</item>
<item>
<title>Obesity: The Search for a Skinny Pill</title>
<link>http://brainwaves.corante.com/archives/2005/11/01/obesity_the_search_for_a_skinny_pill.php</link>
<description>The latest data from the Center of Health Statistics show that 30% of U.S. adults over 21 are obese. The percentage of young people who are overweight has more than tripled since 1980. And among children and teens, 16% are...</description>
<guid isPermaLink="false">37615@/home/corante/public_html/brainwaves/</guid>
<dc:subject>Neuropharma</dc:subject>
<dc:date>2005-11-01T11:25:22-05:00</dc:date>
</item>
<item>
<title>Arena’s Obesity Drug Scores in Phase II Trial</title>
<link>http://brainwaves.corante.com/archives/2005/11/01/arenas_obesity_drug_scores_in_phase_ii_trial.php</link>
<description>Arena Pharmaceuticals (ARNA) is a mid-size San Diego biotech company focused on G-coupled protein receptors (GPCR&apos;s). GPCR&apos;s are a class of receptor molecules that mediate the majority of cell to cell communication in the human body. These receptors are also...</description>
<guid isPermaLink="false">37613@/home/corante/public_html/brainwaves/</guid>
<dc:subject>Neuropharma</dc:subject>
<dc:date>2005-11-01T11:17:06-05:00</dc:date>
</item>
<item>
<title>Using Brain Scans to Figure Out What Women Want</title>
<link>http://brainwaves.corante.com/archives/2005/09/08/using_brain_scans_to_figure_out_what_women_want.php</link>
<description>What will they think of next? MIT&apos;s Technology Review reports on the following: &quot;Drug companies make $2.5 billion a year selling Viagra, Cialis and Levitra to help men enjoy sex. Since more women suffer from sexual dysfunction than men, developing...</description>
<guid isPermaLink="false">4500@/home/corante/public_html/brainwaves/</guid>
<dc:subject>Neuropharma</dc:subject>
<dc:date>2005-09-08T19:02:13-05:00</dc:date>
</item>
<item>
<title>Eyetech Bought by OSI (Neuropharma M&amp;A)</title>
<link>http://brainwaves.corante.com/archives/2005/08/22/eyetech_bought_by_osi_neuropharma_ma.php</link>
<description>From the associated press: &quot;Shares of Eyetech soared this morning after OSI Pharmaceuticals announced it would buy the drug developer for $935 million. Eyetech developed and co-markets Macugen for macular degeneration. OSI will pay $20 per share, a 43 percent...</description>
<guid isPermaLink="false">4492@/home/corante/public_html/brainwaves/</guid>
<dc:subject>Neuropharma</dc:subject>
<dc:date>2005-08-22T19:47:07-05:00</dc:date>
</item>
<item>
<title>Insomnia Science Discussed at NIH</title>
<link>http://brainwaves.corante.com/archives/2005/06/29/insomnia_science_discussed_at_nih.php</link>
<description>From Psychscape: A recent consensus panel was convened at NIH to discusses the specific challenges facing insomnia research and recommended a variety of studies to help clarify the disorder&apos;s underlying mechanisms, natural history, the interaction between insomnia and other conditions,...</description>
<guid isPermaLink="false">4464@/home/corante/public_html/brainwaves/</guid>
<dc:subject>Neuropharma</dc:subject>
<dc:date>2005-06-29T18:50:55-05:00</dc:date>
</item>
<item>
<title>Molecules for the Mind - Tapping Into the Booming Neuropharma Market (April 19th)</title>
<link>http://brainwaves.corante.com/archives/2005/04/05/molecules_for_the_mind_tapping_into_the_booming_neuropharma_market_april_19th.php</link>
<description>What challenges do entrepreneurs face in order to turn a research concept into a successful company with viable treatments? Find out on April 19th at this month&apos;s MIT/Stanford Venture Lab, where Jeffrey Ostrove, CEO of Ceregene, discusses how they overcame...</description>
<guid isPermaLink="false">4416@/home/corante/public_html/brainwaves/</guid>
<dc:subject>Neuropharma</dc:subject>
<dc:date>2005-04-05T22:07:50-05:00</dc:date>
</item>
<item>
<title>Neuropharmaceutical Approval Process - The FDA&apos;s Slow Road</title>
<link>http://brainwaves.corante.com/archives/2005/03/09/neuropharmaceutical_approval_process_the_fdas_slow_road.php</link>
<description>Regulation of neuropharmaceuticals and neurodevices fall under two different centers within the FDA. Pharmaceuticals are overseen by the Center for Drug Evaluation and Research (CDER), while devices are overseen by the Center for Devices and Radiological Health (CDRH). The Current...</description>
<guid isPermaLink="false">4404@/home/corante/public_html/brainwaves/</guid>
<dc:subject>Neuropharma</dc:subject>
<dc:date>2005-03-09T22:46:34-05:00</dc:date>
</item>
<item>
<title>Multiple Sclerosis Drug Tysabri Pulled Off Market</title>
<link>http://brainwaves.corante.com/archives/2005/02/28/multiple_sclerosis_drug_tysabri_pulled_off_market.php</link>
<description>Biogen Idec and Elan announced Monday they have voluntarily withdrawn Tysabri, a drug used to treat multiple sclerosis, after one patient died and another developed a serious disease of the central nervous system after taking it in combination with Avonex...</description>
<guid isPermaLink="false">4398@/home/corante/public_html/brainwaves/</guid>
<dc:subject>Neuropharma</dc:subject>
<dc:date>2005-02-28T11:05:46-05:00</dc:date>
</item>
<item>
<title>The Chemical Architecture of the Human Mind by Tom Ray</title>
<link>http://brainwaves.corante.com/archives/2005/02/05/the_chemical_architecture_of_the_human_mind_by_tom_ray.php</link>
<description>Last year, in a six part series, interdisciplinary neuroecoscientist Tom Ray shared a simplified version of his work on using psychedelics to probe and map the receptor space of the human mind here on Brain Waves. The following is a...</description>
<guid isPermaLink="false">4383@/home/corante/public_html/brainwaves/</guid>
<dc:subject>Neuropharma</dc:subject>
<dc:date>2005-02-05T15:02:12-05:00</dc:date>
</item>


</channel>
</rss>